A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH

NCT04006145 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

NAFLD
NASH

Interventions

DRUG: Elobixibat
DRUG: Placebo oral tablet

Sponsor

Albireo